ENTITY

Therapix Biosciences (TRPX US)

Analysis

Health Care • United States

Therapix Biosciences Ltd provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. Therapix Biosciences serves customers worldwide.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00